These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 29202080)

  • 1. A practical approach for scaling up the alternative strategy for the elimination of lymphatic filariasis in
    Kelly-Hope LA; Stanton MC; Zouré HGM; Kinvi BE; Mikhailov A; Tekle A; King JD
    Glob Health Res Policy; 2017; 2():12. PubMed ID: 29202080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid integrated clinical survey to determine prevalence and co-distribution patterns of lymphatic filariasis and onchocerciasis in a
    Brito M; Paulo R; Van-Dunem P; Martins A; Unnasch TR; Novak RJ; Jacob B; Stanton MC; Molyneux DH; Kelly-Hope LA
    Parasite Epidemiol Control; 2017 Aug; 2(3):71-84. PubMed ID: 29774284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increasing evidence of low lymphatic filariasis prevalence in high risk Loa loa areas in Central and West Africa: a literature review.
    Kelly-Hope LA; Hemingway J; Taylor MJ; Molyneux DH
    Parasit Vectors; 2018 Jun; 11(1):349. PubMed ID: 29907117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identifying co-endemic areas for major filarial infections in sub-Saharan Africa: seeking synergies and preventing severe adverse events during mass drug administration campaigns.
    Cano J; Basáñez MG; O'Hanlon SJ; Tekle AH; Wanji S; Zouré HG; Rebollo MP; Pullan RL
    Parasit Vectors; 2018 Jan; 11(1):70. PubMed ID: 29382363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypo-endemic onchocerciasis hotspots: defining areas of high risk through micro-mapping and environmental delineation.
    Kelly-Hope LA; Unnasch TR; Stanton MC; Molyneux DH
    Infect Dis Poverty; 2015; 4():36. PubMed ID: 26279835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphatic filariasis in the Democratic Republic of Congo; micro-stratification overlap mapping (MOM) as a prerequisite for control and surveillance.
    Kelly-Hope LA; Thomas BC; Bockarie MJ; Molyneux DH
    Parasit Vectors; 2011 Sep; 4():178. PubMed ID: 21923949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loa loa vectors Chrysops spp.: perspectives on research, distribution, bionomics, and implications for elimination of lymphatic filariasis and onchocerciasis.
    Kelly-Hope L; Paulo R; Thomas B; Brito M; Unnasch TR; Molyneux D
    Parasit Vectors; 2017 Apr; 10(1):172. PubMed ID: 28381279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The 6th Meeting of the Global Alliance to Eliminate Lymphatic Filariasis: A half-time review of lymphatic filariasis elimination and its integration with the control of other neglected tropical diseases.
    Addiss D;
    Parasit Vectors; 2010 Oct; 3():100. PubMed ID: 20961435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated risk mapping and landscape characterisation of lymphatic filariasis and loiasis in South West Nigeria.
    Brant TA; Okorie PN; Ogunmola O; Ojeyode NB; Fatunade SB; Davies E; Saka Y; Stanton MC; Molyneux DH; Russell Stothard J; Kelly-Hope LA
    Parasite Epidemiol Control; 2018 Feb; 3(1):21-35. PubMed ID: 29774296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Report of a Scientific Working Group on Serious Adverse Events following Mectizan(R) treatment of onchocerciasis in Loa loa endemic areas.
    Scientific Working Group on Serious Adverse Events in Loa Loa endemic areas
    Filaria J; 2003 Oct; 2 Suppl 1(Suppl 1):S2. PubMed ID: 14975059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Innovative tools for assessing risks for severe adverse events in areas of overlapping Loa loa and other filarial distributions: the application of micro-stratification mapping.
    Kelly-Hope LA; Cano J; Stanton MC; Bockarie MJ; Molyneux DH
    Parasit Vectors; 2014 Jul; 7():307. PubMed ID: 24992829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elimination of lymphatic filariasis: do we have the drugs to complete the job?
    Bockarie MJ; Deb RM
    Curr Opin Infect Dis; 2010 Dec; 23(6):617-20. PubMed ID: 20847694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Test-and-Not-Treat Strategy for Onchocerciasis in Loa loa-Endemic Areas.
    Kamgno J; Pion SD; Chesnais CB; Bakalar MH; D'Ambrosio MV; Mackenzie CD; Nana-Djeunga HC; Gounoue-Kamkumo R; Njitchouang GR; Nwane P; Tchatchueng-Mbouga JB; Wanji S; Stolk WA; Fletcher DA; Klion AD; Nutman TB; Boussinesq M
    N Engl J Med; 2017 Nov; 377(21):2044-2052. PubMed ID: 29116890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can malaria vector control accelerate the interruption of lymphatic filariasis transmission in Africa; capturing a window of opportunity?
    Kelly-Hope LA; Molyneux DH; Bockarie MJ
    Parasit Vectors; 2013 Feb; 6():39. PubMed ID: 23433078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Feasibility of Onchocerciasis Elimination Using a "Test-and-not-treat" Strategy in Loa loa Co-endemic Areas.
    Blok DJ; Kamgno J; Pion SD; Nana-Djeunga HC; Niamsi-Emalio Y; Chesnais CB; Mackenzie CD; Klion AD; Fletcher DA; Nutman TB; de Vlas SJ; Boussinesq M; Stolk WA
    Clin Infect Dis; 2021 Jun; 72(12):e1047-e1055. PubMed ID: 33289025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How Thailand eliminated lymphatic filariasis as a public health problem.
    Rojanapanus S; Toothong T; Boondej P; Thammapalo S; Khuanyoung N; Santabutr W; Prempree P; Gopinath D; Ramaiah KD
    Infect Dis Poverty; 2019 May; 8(1):38. PubMed ID: 31130143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphatic filariasis in Nigeria; micro-stratification overlap mapping (MOM) as a prerequisite for cost-effective resource utilization in control and surveillance.
    Okorie PN; Ademowo GO; Saka Y; Davies E; Okoronkwo C; Bockarie MJ; Molyneux DH; Kelly-Hope LA
    PLoS Negl Trop Dis; 2013; 7(9):e2416. PubMed ID: 24040432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multidimensional complexities of filariasis control in an era of large-scale mass drug administration programmes: a can of worms.
    Molyneux DH; Hopkins A; Bradley MH; Kelly-Hope LA
    Parasit Vectors; 2014 Aug; 7():363. PubMed ID: 25128408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implications for annual retesting after a test-and-not-treat strategy for onchocerciasis elimination in areas co-endemic with Loa loa infection: an observational cohort study.
    Pion SD; Nana-Djeunga H; Niamsi-Emalio Y; Chesnais CB; Deléglise H; Mackenzie C; Stolk W; Fletcher DA; Klion AD; Nutman TB; Boussinesq M; Kamgno J
    Lancet Infect Dis; 2020 Jan; 20(1):102-109. PubMed ID: 31676244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Point-of-care quantification of blood-borne filarial parasites with a mobile phone microscope.
    D'Ambrosio MV; Bakalar M; Bennuru S; Reber C; Skandarajah A; Nilsson L; Switz N; Kamgno J; Pion S; Boussinesq M; Nutman TB; Fletcher DA
    Sci Transl Med; 2015 May; 7(286):286re4. PubMed ID: 25947164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.